Discovery of cyclicsulfonamide derivatives as 11 beta-hydroxysteroid dehydrogenase 1 inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Se Hoan | - |
dc.contributor.author | Ramu, Ravirala | - |
dc.contributor.author | Kwon, Sung Wook | - |
dc.contributor.author | Lee, Su-Hee | - |
dc.contributor.author | Kim, Chi Hyun | - |
dc.contributor.author | Kang, Seung Kyu | - |
dc.contributor.author | Rhee, Sang Dal | - |
dc.contributor.author | Bae, Myung Ae | - |
dc.contributor.author | Ahn, Sung Hoon | - |
dc.contributor.author | Ha, Duck Chan | - |
dc.contributor.author | Cheon, Hyae Gyeong | - |
dc.contributor.author | Kim, Ki Young | - |
dc.contributor.author | Ahn, Jin Hee | - |
dc.date.accessioned | 2021-09-08T05:10:42Z | - |
dc.date.available | 2021-09-08T05:10:42Z | - |
dc.date.created | 2021-06-11 | - |
dc.date.issued | 2010-02-01 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/117007 | - |
dc.description.abstract | A new series of cyclic sulfonamide derivatives was synthesized and evaluated for their ability to inhibit 11 beta-HSD1. Cyclic sulfonamides with phenylacetyl substituents at the 2-position showed nanomolar inhibitory activities. Among them, compound 4e exhibited a good in vitro inhibitory activity and selectivity toward human 11 beta-HSD2. (C) 2009 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | SELECTIVE INHIBITORS | - |
dc.subject | METABOLIC SYNDROME | - |
dc.subject | VISCERAL OBESITY | - |
dc.subject | TYPE-1 | - |
dc.subject | MICE | - |
dc.subject | POTENT | - |
dc.title | Discovery of cyclicsulfonamide derivatives as 11 beta-hydroxysteroid dehydrogenase 1 inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ha, Duck Chan | - |
dc.identifier.doi | 10.1016/j.bmcl.2009.12.035 | - |
dc.identifier.scopusid | 2-s2.0-74049154856 | - |
dc.identifier.wosid | 000273783800061 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.20, no.3, pp.1065 - 1069 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 20 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 1065 | - |
dc.citation.endPage | 1069 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | SELECTIVE INHIBITORS | - |
dc.subject.keywordPlus | METABOLIC SYNDROME | - |
dc.subject.keywordPlus | VISCERAL OBESITY | - |
dc.subject.keywordPlus | TYPE-1 | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordAuthor | 11 beta-Hydroxysteroid dehydrogenase 1 | - |
dc.subject.keywordAuthor | Cyclic sulfonamide | - |
dc.subject.keywordAuthor | Diabetes | - |
dc.subject.keywordAuthor | Inhibitor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.